Ignite Creation Date:
2024-05-05 @ 11:32 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00077415
Status:
COMPLETED
Last Update Posted:
2013-05-15
First Post:
2004-02-10
Brief Title:
3-AP and Gemcitabine as Second-Line Therapy in Treating Patients With Stage III or Stage IV Recurrent Non-Small Cell Lung Cancer
Sponsor:
Organization:
National Cancer Institute NCI